A 31-year-old man presented with pharyngeal pain and purpura on the right dorsal surface of the hand for 1 week. The complete blood count showed leukopenia and thrombocytopenia (white blood cell count, 1.8 × 109/L; platelet count, 51 × 109/L). Coagulation tests revealed the following: prothrombin time–international normalized ratio (PT–INR) of 1.46; fibrinogen level of 36 mg/dL; fibrin degradation products (FDP) level of 50.9 μg/mL; D-dimer level of 60.6 μg/mL; and thrombin–antithrombin III (TAT) complex level of 54.6 ng/mL. These results indicated disseminated intravascular coagulopathy (DIC). A bone marrow examination revealed hypocellularity with 77 % abnormal promyelocytes. Promyelocytes were variable in size, and contained round, ovoid, distorted, or folded nuclei, as well as rich cytoplasm with abundant azurophilic granules. Chédiak–Higashi-like granules were frequently observed in these promyelocytes (Fig. 1a). Auer bodies were often thick, and some were waxy (Fig. 1b). A diagnosis of acute promyelocytic leukemia (APL) was made on the detection of the t(15;17) (q22;q21) translocation and the resultant PML/RARA fusion transcript. FLT3–ITD mutation was negative.
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.